Profound Medical Corp Stock Total Asset
| PRN Stock | CAD 10.70 0.14 1.29% |
Profound Medical Corp fundamentals help investors to digest information that contributes to Profound Medical's financial success or failures. It also enables traders to predict the movement of Profound Stock. The fundamental analysis module provides a way to measure Profound Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Profound Medical stock.
| Last Reported | Projected for Next Year | ||
| Total Assets | 43.9 M | 46.2 M | |
| Intangibles To Total Assets | 0.01 | 0.01 |
Profound | Total Asset |
Profound Medical Corp Company Total Asset Analysis
Profound Medical's Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
Current Profound Medical Total Asset | 43.91 M |
Most of Profound Medical's fundamental indicators, such as Total Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Profound Medical Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Profound Total Asset Driver Correlations
Understanding the fundamental principles of building solid financial models for Profound Medical is extremely important. It helps to project a fair market value of Profound Stock properly, considering its historical fundamentals such as Total Asset. Since Profound Medical's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Profound Medical's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Profound Medical's interrelated accounts and indicators.
Click cells to compare fundamentals
Total Asset is typically divided on the balance sheet on current asset and long-term asset. Long-term is the value of company property and other capital assets that are expected to be useable for more than one year. Long term assets are reported net of depreciation. On the other hand current assets are assets that are expected to be sold or converted to cash as part of normal business operation.
| Competition |
Profound Total Assets
Total Assets |
|
Based on the latest financial disclosure, Profound Medical Corp has a Total Asset of 43.91 M. This is 99.42% lower than that of the Health Care Equipment & Supplies sector and 98.59% lower than that of the Health Care industry. The total asset for all Canada stocks is 99.85% higher than that of the company.
Profound Total Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Profound Medical's direct or indirect competition against its Total Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Profound Medical could also be used in its relative valuation, which is a method of valuing Profound Medical by comparing valuation metrics of similar companies.Profound Medical is currently under evaluation in total asset category among its peers.
Profound Fundamentals
| Return On Equity | -0.9 | ||||
| Return On Asset | -0.45 | ||||
| Operating Margin | (3.17) % | ||||
| Current Valuation | 238.26 M | ||||
| Shares Outstanding | 24.66 M | ||||
| Shares Owned By Insiders | 8.39 % | ||||
| Shares Owned By Institutions | 43.81 % | ||||
| Number Of Shares Shorted | 92.65 K | ||||
| Price To Book | 7.25 X | ||||
| Price To Sales | 29.81 X | ||||
| Revenue | 7.2 M | ||||
| Gross Profit | 3.02 M | ||||
| EBITDA | (25.97 M) | ||||
| Net Income | (28.57 M) | ||||
| Cash And Equivalents | 27.05 M | ||||
| Cash Per Share | 0.25 X | ||||
| Total Debt | 7.94 M | ||||
| Debt To Equity | 60.50 % | ||||
| Current Ratio | 4.65 X | ||||
| Book Value Per Share | 1.26 X | ||||
| Cash Flow From Operations | (22.3 M) | ||||
| Short Ratio | 9.63 X | ||||
| Earnings Per Share | (1.90) X | ||||
| Target Price | 25.03 | ||||
| Number Of Employees | 131 | ||||
| Beta | 0.83 | ||||
| Market Capitalization | 267.83 M | ||||
| Total Asset | 43.91 M | ||||
| Retained Earnings | (217.93 M) | ||||
| Working Capital | 35.53 M | ||||
| Net Asset | 43.91 M |
About Profound Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Profound Medical Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Profound Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Profound Medical Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Profound Medical
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Profound Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Profound Medical will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Profound Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Profound Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Profound Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Profound Medical Corp to buy it.
The correlation of Profound Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Profound Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Profound Medical Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Profound Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Profound Medical Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.